Related Experiment Video
Updated: Mar 15, 2026

09:41
Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
14.0K
Monocytes Chat With Atherosclerotic Lesions
1From the Institute for Cardiovascular Prevention, LMU Munich, Germany; Academic Medical Center, Department of Pathology, Amsterdam University, The Netherlands; and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany. oliver.soehnlein@gmail.com.
Arteriosclerosis, Thrombosis, and Vascular Biology
|August 26, 2016
Summary
No abstract available in PubMed .
Related Concept Videos
Inflammation
63.6K
Overview
63.6K
Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease II: Pathophysiology
873
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
873
Atherosclerosis III: Management
562
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562

